Suppr超能文献

一项关于类风湿关节炎患者单次关节腔内注射依那西普或糖皮质激素的随机对照研究。

A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.

作者信息

Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm C C, Rogind H, Boesen M, Danneskiold-Samsøe B, Torp-Pedersen S

机构信息

The Parker Institute, Frederiksberg Hospital, Copenhagen, Denmark.

出版信息

Scand J Rheumatol. 2006 Sep-Oct;35(5):341-5. doi: 10.1080/03009740600844530.

Abstract

OBJECTIVE

Glucocorticosteroids are used successfully for both systemic and intra-articular treatment of arthritis. Inhibitors of tumour necrosis factor alpha (TNF-alpha) are effective when administered systemically and this study was performed to compare the effect of intra-articular injection of these two substances.

DESIGN

A randomized, parallel-group, double-blind study with an independent observer. Thirty-eight patients with flare of arthritis in a single joint (wrist, elbow, or knee) were given intra-articular 25 mg etanercept or 40 mg methylprednisolone guided by ultrasound. The primary end-point was the 4-week change in pain in the target joint. The study complied with Good Clinical Practice (GCP) and the Consolidated Standards for Reporting of Trials (CONSORT) statement.

RESULTS

At 4 weeks no difference in pain outcome between treatment groups was demonstrated by analysis of covariance (ANCOVA). Pain on the Visual Analogue Scale (VAS) for etanercept was baseline mean 40.9 (SD 19.6) mm, follow-up 32.7 (29.1) mm (p = 0.29), methylprednisolone baseline mean 47.1 (29.6) mm, follow-up 25.3 (24.7) mm (p<0.001). The investigator's evaluation was for etanercept baseline 30.6 (21.2) mm, follow-up 17.1 (15.5) mm (p = 0.054) and for methylprednisolone baseline 35.4 (26.4) mm, follow-up 11.9 (14.6) mm (p = 0.012). Joint swelling was for etanercept baseline 1.78 (0.73), follow-up 1.25 (0.77) (p = 0.015) and for methylprednisolone baseline 1.74 (0.73), follow-up 0.71 (0.77) (p<0.001). One serious adverse event was seen in a patient treated with methylprednisolone injection.

CONCLUSION

Although no difference between groups was demonstrated, the within-group effect of methylprednisolone was more marked than that of etanercept. Injections with 25 mg etanercept were well tolerated. However, the cost of etanercept will presumably limit its use to patients with adverse reactions to steroid.

摘要

目的

糖皮质激素已成功用于关节炎的全身治疗和关节内治疗。肿瘤坏死因子α(TNF-α)抑制剂全身给药时有效,本研究旨在比较这两种药物关节内注射的效果。

设计

一项由独立观察者进行的随机、平行组、双盲研究。38例单关节(腕关节、肘关节或膝关节)关节炎发作的患者在超声引导下接受关节内注射25mg依那西普或40mg甲基强的松龙。主要终点是目标关节疼痛在4周内的变化。该研究遵循了良好临床实践(GCP)和试验报告统一标准(CONSORT)声明。

结果

4周时,通过协方差分析(ANCOVA)未显示治疗组之间在疼痛结果上有差异。依那西普组视觉模拟量表(VAS)疼痛评分基线均值为40.9(标准差19.6)mm,随访时为32.7(29.1)mm(p = 0.29);甲基强的松龙组基线均值为47.1(29.6)mm,随访时为25.3(24.7)mm(p<0.001)。研究者评估依那西普组基线为30.6(21.2)mm,随访时为17.1(15.5)mm(p = 0.054);甲基强的松龙组基线为35.4(26.4)mm,随访时为11.9(14.6)mm(p = 0.012)。关节肿胀情况,依那西普组基线为1.78(0.73),随访时为1.25(

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验